1.
Bankar A, Siriwardena TP, Rizoska B, RydergÄrd C, Kylefjord H, Rraklli V, Eneroth A, Pinho P, Norin S, Bylund J, Moses S, Bethell R, Kavanagh S, Maclean N, Gronda M, Wang X, Hurren R, Minden MD, Targett-Adams P, Schimmer AD, Albertella M. Novel L-nucleoside analogue, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia. Haematologica 2021; 106(2):574-579; https://doi.org/10.3324/haematol.2019.226795.